Protese-activated receptor PAR4 (ZCHEMR2)
    1.
    发明授权
    Protese-activated receptor PAR4 (ZCHEMR2) 失效
    Protese激活受体PAR4(ZCHEMR2)

    公开(公告)号:US6111075A

    公开(公告)日:2000-08-29

    申请号:US53866

    申请日:1998-04-01

    CPC分类号: C07K14/705 A61K38/00

    摘要: The present invention relates to polynucleotide and polypeptide molecules for PAR4, a novel member of the protease-activated receptor family. The polypeptides, and polynucleotides encoding them, mediate biological responses and/or cellular signaling in response to proteases. Protease cleavage of PAR4 exposes a PAR4 extracellular amino terminal portion that serves as a ligand for the PAR4 receptor. PAR4 may be used as a target in drug screening, and further used to identify proteinaceous or non-proteinaceous PAR4 agonists and antagonists. The present invention also includes antibodies to the PAR4 polypeptides.

    摘要翻译: 本发明涉及用于PAR4(蛋白酶活化受体家族的新成员)的多核苷酸和多肽分子。 多肽和编码它们的多核苷酸介导响应于蛋白酶的生物反应和/或细胞信号传导。 PAR4的蛋白酶切割暴露了作为PAR4受体配体的PAR4细胞外氨基末端部分。 PAR4可用作药物筛选中的靶标,并进一步用于鉴定蛋白质或非蛋白质PAR4激动剂和拮抗剂。 本发明还包括对PAR4多肽的抗体。

    Protease-activated receptor PAR4 (ZCHEMR2)

    公开(公告)号:US07122342B1

    公开(公告)日:2006-10-17

    申请号:US09371333

    申请日:1999-08-10

    IPC分类号: C12N15/12

    CPC分类号: C07K14/705

    摘要: The present invention relates to polynucleotide and polypeptide molecules for PAR4, a novel member of the protease-activated receptor family. The polypeptides, and polynucleotides encoding them, mediate biological responses and/or cellular signaling in response to proteases. Protease cleavage of PAR4 exposes a PAR4 extracellular amino terminal portion that serves as a ligand for the PAR4 receptor. PAR4 may be used as a target in drug screening, and further used to identify proteinaceous or non-proteinaceous PAR4 agonists and antagonists. The present invention also includes antibodies to the PAR4 polypeptides.

    Protease-activated receptor PAR4 ZCHEMR2
    3.
    发明授权
    Protease-activated receptor PAR4 ZCHEMR2 失效
    蛋白酶激活受体PAR4 ZCHEMR2

    公开(公告)号:US06436400B1

    公开(公告)日:2002-08-20

    申请号:US09479130

    申请日:2000-01-07

    IPC分类号: C07K1628

    CPC分类号: C07K14/705 A61K38/00

    摘要: The present invention relates to polynucleotide and polypeptide molecules for PAR4, a novel member of the protease-activated receptor family. The polypeptides, and polynucleotides encoding them, mediate biological responses and/or cellular signaling in response to proteases. Protease cleavage of PAR4 exposes a PAR4 extracellular amino terminal portion that serves as a ligand for the PAR4 receptor. PAR4 may be used as a target in drug screening, and further used to identify proteinaceous or non-proteinaceous PAR4 agonists and antagonists. The present invention also includes antibodies to the PAR4 polypeptides.

    摘要翻译: 本发明涉及用于PAR4(蛋白酶活化受体家族的新成员)的多核苷酸和多肽分子。 多肽和编码它们的多核苷酸介导响应于蛋白酶的生物反应和/或细胞信号传导。 PAR4的蛋白酶切割暴露了作为PAR4受体配体的PAR4细胞外氨基末端部分。 PAR4可用作药物筛选中的靶标,并进一步用于鉴定蛋白质或非蛋白质PAR4激动剂和拮抗剂。 本发明还包括对PAR4多肽的抗体。

    Protease-activated receptor PAR4 (ZCHEMR2)

    公开(公告)号:US07084253B2

    公开(公告)日:2006-08-01

    申请号:US10187049

    申请日:2002-06-28

    IPC分类号: C07K14/705

    CPC分类号: C07K14/705 A61K38/00

    摘要: The present invention relates to polynucleotide and polypeptide molecules for PAR4, a novel member of the protease-activated receptor family. The polypeptides, and polynucleotides encoding them, mediate biological responses and/or cellular signaling in response to proteases. Protease cleavage of PAR4 exposes a PAR4 extracellular amino terminal portion that serves as a ligand for the PAR4 receptor. PAR4 may be used as a target in drug screening, and further used to identify proteinaceous or non-proteinaceous PAR4 agonists and antagonists. The present invention also includes antibodies to the PAR4 polypeptides.

    Soluble receptor BR43x2
    7.
    发明授权
    Soluble receptor BR43x2 有权
    可溶性受体BR43x2

    公开(公告)号:US07772365B2

    公开(公告)日:2010-08-10

    申请号:US11458968

    申请日:2006-07-20

    摘要: Soluble, secreted tumor necrosis factor receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise one cysteine-rich repeat that is homologous to other tumor necrosis factor receptors, such as transmembrane activator and CAML-interactor (TACI). The polypeptides may be used for detecting ligands, agonists and antagonists. The polypeptides may also be used in methods that modulate B cell activation.

    摘要翻译: 公开了可溶性,分泌的肿瘤坏死因子受体多肽,编码多肽的多核苷酸,以及相关的组合物和方法。 多肽包含与其它肿瘤坏死因子受体如跨膜激活因子和CAML相互作用因子(TACI)同源的富含半胱氨酸的重复序列。 多肽可用于检测配体,激动剂和拮抗剂。 多肽也可用于调节B细胞活化的方法。

    Human transcription factor ZGCL-1
    8.
    发明授权
    Human transcription factor ZGCL-1 失效
    人转录因子ZGCL-1

    公开(公告)号:US06420525B1

    公开(公告)日:2002-07-16

    申请号:US09137223

    申请日:1998-08-19

    IPC分类号: C07K1447

    摘要: Novel ZGCL-1 transcription factor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides, agonists and antagonists may be used within methods for promoting the proliferation and/or differentiation of testis cells, and may also be used in the development of male-specific contraceptives and infertility treatments.

    摘要翻译: 公开了新型ZGCL-1转录因子多肽,编码多肽的多核苷酸,以及相关组合物和方法。 可以在用于促进​​睾丸细胞增殖和/或分化的方法中使用多肽,激动剂和拮抗剂,并且还可用于开发男性特异性避孕药和不育症治疗。